IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics
Open Access
- 23 March 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Biology
- Vol. 18 (3) , e3000646
Abstract
Interleukin 23 (IL-23) triggers pathogenic features in pro-inflammatory, IL-17-secreting T cells (Th17 and Tγδ17) that play a key role in the development of inflammatory diseases. However, the IL-23 signaling cascade remains largely undefined. Here, we used quantitative phosphoproteomics to characterize IL-23 signaling in primary murine Th17 cells. We quantified 6,888 phosphorylation sites in Th17 cells and found 168 phosphorylations regulated upon IL-23 stimulation. IL-23 increased the phosphorylation of the myosin regulatory light chain (RLC), an actomyosin contractibility marker, in Th17 and Tγδ17 cells. IL-23-induced RLC phosphorylation required Janus kinase 2 (JAK2) and Rho-associated protein kinase (ROCK) catalytic activity, and further study of the IL-23/ROCK connection revealed an unexpected role of IL-23 in the migration of Tγδ17 and Th17 cells through ROCK activation. In addition, pharmacological inhibition of ROCK reduced Tγδ17 recruitment to inflamed skin upon challenge with inflammatory agent Imiquimod. This work (i) provides new insights into phosphorylation networks that control Th17 cells, (ii) widely expands the current knowledge on IL-23 signaling, and (iii) contributes to the increasing list of immune cells subsets characterized by global phosphoproteomic approaches.Keywords
Funding Information
- Ministerio de Economía y Competitividad (SAF2013-43833-R)
- Ministerio de Economía y Competitividad (SAF2016-78180-R)
- Ministerio de Economía y Competitividad (RYC-2012-10252)
- Ministerio de Economía y Competitividad (BES-2015-074053; SAF2014-55579-R)
This publication has 68 references indexed in Scilit:
- IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targetingNature Reviews Gastroenterology & Hepatology, 2018
- Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic InterventionsImmunity, 2015
- IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseasesNature Medicine, 2015
- IL-12 family cytokines: immunological playmakersNature Immunology, 2012
- Kinase inhibitors in the treatment of immune-mediated diseaseF1000 Medicine Reports, 2012
- Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 AxisThe Journal of Immunology, 2009
- IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathwaysNature Immunology, 2007
- Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brainNature, 2003
- A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23RThe Journal of Immunology, 2002
- Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12Immunity, 2000